CADL vs ENTX: stock comparison and AI forecast
Candel Therapeutics, Inc. (CADL) and Entera Bio Ltd. (ENTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CADL Candel Therapeutics, Inc.
- Market Cap
- $675M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
ENTX Entera Bio Ltd.
- Market Cap
- $535M
- P/E Ratio
- 9.4x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CADL is 1.3 times larger than ENTX by market capitalization ($675M against $535M).
- ENTX carries 1.68 times debt per unit of equity, against 0.65 times for CADL.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CADL | ENTX |
|---|---|---|
| Market Cap | $675M | $535M |
| P/E Ratio | – | 9.36x |
| P/B Ratio | 5.35x | 73.63x |
| EPS | $-1.15 | $0.33 |
| Book Value/Share | $1.65 | $0.04 |
| Revenue/Share | – | $0.00 |
| FCF/Share | $-0.75 | $-0.06 |
Profitability & Margins
| Metric | CADL | ENTX |
|---|---|---|
| ROE | -70.2% | – |
| ROA | -42.5% | – |
| ROIC | -36.8% | -82.9% |
Financial Health
| Metric | CADL | ENTX |
|---|---|---|
| Current Ratio | 16.09x | 8.98x |
| D/E Ratio | 0.65x | 1.68x |
| Financial Leverage | 1.65x | 2.68x |
| Interest Coverage | -17.0x | – |
| Working Capital | $191M | $17M |
Cash Flow
| Metric | CADL | ENTX |
|---|---|---|
| Operating Cash Flow | -$56M | -$11M |
| Free Cash Flow | -$57M | -$11M |
| Capital Spending | -$1M | -$70K |
Operational Efficiency
| Metric | CADL | ENTX |
|---|---|---|
| Asset Turnover | – | 0.00x |
| Fixed Assets Turnover | – | 0.0x |
Income Statement
| Metric | CADL | ENTX |
|---|---|---|
| Total Revenue | – | $0.00M |
| Operating Income | -$72M | -$14M |
| Net Income | -$89M | – |
| R&D Expense | $49M | $9M |
| SG&A Expense | – | $550K |
| Cost of Goods Sold | – | $0.00M |
Dividend & Shareholder Information
| Metric | CADL | ENTX |
|---|---|---|
| Shares Outstanding | 77M | 173M |
| EPS Growth | – | 32.0% |
CADL vs ENTX: stock comparison and AI forecast
Which is bigger, CADL or ENTX?
CADL is 1.3 times larger than ENTX by market capitalization ($675M against $535M).
Which one does Intratio's AI model rank higher, CADL or ENTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.